Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Suzanne L. Advani"'
Autor:
Lisa Y. Q. Hong, Emily S. H. Yeung, Duc Tin Tran, Veera Ganesh Yerra, Harmandeep Kaur, M. D. Golam Kabir, Suzanne L. Advani, Youan Liu, Sri Nagarjun Batchu, Andrew Advani
Publikováno v:
Disease Models & Mechanisms, Vol 16, Iss 9 (2023)
Externí odkaz:
https://doaj.org/article/9ce26968793046ee9fdc8c7f8ae9040d
Autor:
Veera Ganesh Yerra, Sri Nagarjun Batchu, Harmandeep Kaur, MD Golam Kabir, Youan Liu, Suzanne L. Advani, Duc Tin Tran, Shadi Sadeghian, Phelopater Sedrak, Filio Billia, Uros Kuzmanov, Anthony O. Gramolini, Deema O. Qasrawi, Evgeniy V. Petrotchenko, Christoph H. Borchers, Kim A. Connelly, Andrew Advani
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 9 (2023)
Inflammation promotes adverse ventricular remodeling, a common antecedent of heart failure. Here, we set out to determine how inflammatory cells affect cardiomyocytes in the remodeling heart. Pathogenic cardiac macrophages induced an IFN response in
Externí odkaz:
https://doaj.org/article/0c5911e4a2bf433aac0c14bc3122354f
Autor:
Karina Thieme, Syamantak Majumder, Angela S. Brijmohan, Sri N. Batchu, Bridgit B. Bowskill, Tamadher A. Alghamdi, Suzanne L. Advani, M. Golam Kabir, Youan Liu, Andrew Advani
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract The therapeutic targeting of prostanoid subtype receptors may slow the development of chronic kidney disease (CKD) through mechanisms that are distinct from those of upstream COX inhibition. Here, employing multiple experimental models of CK
Externí odkaz:
https://doaj.org/article/3c7f7c6c5c3f478c808baefc6898c731
Autor:
Angela S. Brijmohan, Sri N. Batchu, Syamantak Majumder, Tamadher A. Alghamdi, Karina Thieme, Sarah McGaugh, Youan Liu, Suzanne L. Advani, Bridgit B. Bowskill, M. Golam Kabir, Laurette Geldenhuys, Ferhan S. Siddiqi, Andrew Advani
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
To contend with the deleterious effects of accumulating misfolded protein aggregates or damaged organelles cells rely on a system of quality control processes, among them the autophagy-lysosome pathway. This pathway is itself controlled by a master r
Externí odkaz:
https://doaj.org/article/c86c2dcce1284f3e9217269d289233bf
Autor:
Harmandeep Kaur, Veera Ganesh Yerra, Sri Nagarjun Batchu, Duc Tin Tran, M. D. Golam Kabir, Youan Liu, Suzanne L. Advani, Phelopater Sedrak, Laurette Geldenhuys, Karthik K. Tennankore, Penelope Poyah, Ferhan S. Siddiqi, Andrew Advani
Publikováno v:
British Journal of Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c327d9d06f9cb5a5075dd65b1279b95
https://doi.org/10.1111/bph.16101
https://doi.org/10.1111/bph.16101
Autor:
Suzanne L. Advani, Youan Liu, Veera Ganesh Yerra, Ferhan S. Siddiqi, Sri N. Batchu, Andrew Advani, Golam Kabir, Kim A. Connelly
Publikováno v:
Cardiovascular Drugs and Therapy. 36:619-632
Although the cardioprotective benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors are now widely appreciated, the mechanisms underlying these benefits remain unresolved. Tumor necrosis factor receptor superfamily member 12a (Tnfrsf12a) is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3db3af0bf3e0353e1c627d1aa84d84e
https://doi.org/10.1007/s10557-021-07190-2
https://doi.org/10.1007/s10557-021-07190-2
Autor:
Veera Ganesh Yerra, Youan Liu, Andrew Advani, M. Golam Kabir, Suzanne L. Advani, Harmandeep Kaur, Sri N. Batchu, Thomas Klein
Publikováno v:
Diabetes. 70:759-771
The causes of the increased risk of severe coronavirus disease 2019 (COVID-19) in people with diabetes are unclear. It has been speculated that renin-angiotensin system (RAS) blockers may promote COVID-19 by increasing ACE2, which severe acute respir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459cdf7d321c1d77bd9c67aa13ac28a4
https://doi.org/10.2337/db20-0765
https://doi.org/10.2337/db20-0765
Autor:
Li-Hao Chen, Suzanne L Advani, Kerri Thai, M Golam Kabir, Manish M Sood, Ian W Gibson, Darren A Yuen, Kim A Connelly, Philip A Marsden, Darren J Kelly, Richard E Gilbert, Andrew Advani
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e92227 (2014)
The progressive decline of renal function in chronic kidney disease (CKD) is characterized by both disruption of the microvascular architecture and the accumulation of fibrotic matrix. One angiogenic pathway recently identified as playing an essentia
Externí odkaz:
https://doaj.org/article/512a27c8bad64906a8763177ff40c448
Autor:
Veera Ganesh, Yerra, Sri Nagarjun, Batchu, Golam, Kabir, Suzanne L, Advani, Youan, Liu, Ferhan S, Siddiqi, Kim A, Connelly, Andrew, Advani
Publikováno v:
Cardiovascular drugs and therapy. 36(4)
Although the cardioprotective benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors are now widely appreciated, the mechanisms underlying these benefits remain unresolved. Tumor necrosis factor receptor superfamily member 12a (Tnfrsf12a) is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d7ea49ef3a84e6a79062e7a31a2827ef
https://pubmed.ncbi.nlm.nih.gov/33886003
https://pubmed.ncbi.nlm.nih.gov/33886003
Autor:
Andrew Advani, Thomas Klein, Youan Liu, Golam Kabir, Suzanne L. Advani, Veera Ganesh Yerra, Harmandeep Kaur, Sri Nagarjun Batchu, Ada Admin
The causes of the increased risk of severe COVID-19 in persons with diabetes are unclear. It has been speculated that renin angiotensin system (RAS) blockers may promote COVID-19 by increasing ACE2, which SARS-CoV-2 uses to enter host cells, along wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::426bcce674d80db35c16ac4b2fa09c39
https://doi.org/10.2337/figshare.13342160.v1
https://doi.org/10.2337/figshare.13342160.v1
